by George Citroner | Nov 16, 2023 | Uncategorized
A high-profile clinical trial of the obesity drug Wegovy has raised hopes that it may also deliver significant cardiovascular benefits beyond weight loss. The trial, funded by Wegovy’s maker Novo Nordisk, found that the use of the injected drug semaglutide led to a...
by George Citroner | Nov 11, 2023 | Uncategorized
A health care crisis is silently brewing across America. Over 10 million people, including many children, have been abruptly cut off from critical health services in recent weeks, according to KFF, formerly known as the Kaiser Family Foundation, a nonprofit...
by George Citroner | Nov 8, 2023 | Uncategorized
The U.S. Food and Drug Administration officially approved Eli Lilly’s diabetes drug Mounjaro for treatment of obesity. Overweight people will also be able to take the drug if they have at least one weight-related condition such as high blood pressure, type 2 diabetes,...
